Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Hemorrhage | 70 | 2024 | 2660 | 6.240 |
Why?
|
Stroke | 50 | 2024 | 9962 | 3.350 |
Why?
|
Liver Transplantation | 18 | 2016 | 2325 | 1.790 |
Why?
|
Brain Ischemia | 13 | 2022 | 3127 | 1.720 |
Why?
|
Atrial Fibrillation | 23 | 2024 | 5209 | 1.600 |
Why?
|
Genome-Wide Association Study | 44 | 2024 | 12626 | 1.480 |
Why?
|
Fatty Liver | 10 | 2019 | 778 | 1.430 |
Why?
|
Reperfusion Injury | 7 | 2014 | 1023 | 1.210 |
Why?
|
Genetic Predisposition to Disease | 30 | 2024 | 17790 | 1.160 |
Why?
|
Cerebrovascular Disorders | 3 | 2023 | 1501 | 1.080 |
Why?
|
Microdialysis | 3 | 2017 | 160 | 1.070 |
Why?
|
Polymorphism, Single Nucleotide | 25 | 2024 | 15789 | 0.980 |
Why?
|
Hematoma | 11 | 2021 | 769 | 0.970 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 2 | 2015 | 88 | 0.960 |
Why?
|
Semaphorins | 1 | 2023 | 97 | 0.860 |
Why?
|
Capillaries | 3 | 2024 | 744 | 0.790 |
Why?
|
Cerebral Amyloid Angiopathy | 7 | 2024 | 892 | 0.740 |
Why?
|
Brain Diseases | 2 | 2020 | 1540 | 0.730 |
Why?
|
Subarachnoid Space | 2 | 2021 | 81 | 0.710 |
Why?
|
Mendelian Randomization Analysis | 9 | 2024 | 998 | 0.700 |
Why?
|
Boxing | 1 | 2019 | 17 | 0.690 |
Why?
|
Risk Factors | 60 | 2024 | 74359 | 0.690 |
Why?
|
Liver | 13 | 2022 | 7509 | 0.680 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2015 | 1135 | 0.660 |
Why?
|
Skin | 9 | 2024 | 4466 | 0.660 |
Why?
|
Hepatocytes | 3 | 2019 | 1229 | 0.660 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2018 | 24 | 0.640 |
Why?
|
Prazosin | 1 | 2018 | 95 | 0.640 |
Why?
|
Humans | 207 | 2024 | 760621 | 0.630 |
Why?
|
Fibrinolytic Agents | 3 | 2024 | 2167 | 0.620 |
Why?
|
Genetic Variation | 14 | 2023 | 6551 | 0.610 |
Why?
|
Hypertension | 13 | 2024 | 8594 | 0.610 |
Why?
|
Early Ambulation | 1 | 2018 | 49 | 0.610 |
Why?
|
Skin Temperature | 1 | 2018 | 96 | 0.590 |
Why?
|
Apolipoprotein E4 | 4 | 2020 | 707 | 0.580 |
Why?
|
Transcription Factor CHOP | 2 | 2015 | 68 | 0.580 |
Why?
|
Oxidative Phosphorylation | 3 | 2015 | 495 | 0.570 |
Why?
|
Myocardial Infarction | 8 | 2023 | 11891 | 0.570 |
Why?
|
Propranolol | 1 | 2018 | 489 | 0.550 |
Why?
|
Cerebral Ventricles | 2 | 2019 | 542 | 0.550 |
Why?
|
Electrocardiography | 4 | 2024 | 6414 | 0.540 |
Why?
|
Cytokines | 6 | 2019 | 7343 | 0.530 |
Why?
|
Blood Circulation | 1 | 2017 | 249 | 0.530 |
Why?
|
Aneurysm, Ruptured | 1 | 2021 | 460 | 0.520 |
Why?
|
Neurology | 2 | 2024 | 779 | 0.520 |
Why?
|
Autophagy | 2 | 2015 | 1337 | 0.520 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2016 | 113 | 0.520 |
Why?
|
Artificial Intelligence | 4 | 2024 | 2557 | 0.520 |
Why?
|
Tissue Donors | 5 | 2013 | 2313 | 0.510 |
Why?
|
Male | 126 | 2024 | 359744 | 0.500 |
Why?
|
Liver Neoplasms | 9 | 2014 | 4319 | 0.500 |
Why?
|
Hepatitis E virus | 1 | 2016 | 71 | 0.500 |
Why?
|
Proto-Oncogene Proteins | 3 | 2015 | 4490 | 0.500 |
Why?
|
Middle Aged | 97 | 2024 | 220352 | 0.500 |
Why?
|
Hepatitis E | 1 | 2016 | 75 | 0.500 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2290 | 0.500 |
Why?
|
Hepatectomy | 3 | 2011 | 559 | 0.490 |
Why?
|
Spectrum Analysis | 1 | 2017 | 453 | 0.490 |
Why?
|
Urinary Tract Infections | 3 | 2018 | 814 | 0.490 |
Why?
|
Hematoma, Subdural, Intracranial | 1 | 2015 | 30 | 0.490 |
Why?
|
Collagen Type IV | 3 | 2024 | 127 | 0.490 |
Why?
|
Female | 122 | 2024 | 391270 | 0.470 |
Why?
|
Aged | 88 | 2024 | 169152 | 0.470 |
Why?
|
Apolipoprotein E2 | 5 | 2018 | 135 | 0.470 |
Why?
|
Spectrometry, Fluorescence | 3 | 2004 | 687 | 0.450 |
Why?
|
End Stage Liver Disease | 3 | 2014 | 353 | 0.450 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2013 | 93 | 0.450 |
Why?
|
Photoelectron Spectroscopy | 1 | 2013 | 12 | 0.440 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2021 | 1032 | 0.440 |
Why?
|
Aged, 80 and over | 51 | 2024 | 58995 | 0.430 |
Why?
|
Tissue Survival | 1 | 2013 | 119 | 0.430 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 1259 | 0.410 |
Why?
|
Triglycerides | 5 | 2022 | 2476 | 0.410 |
Why?
|
Pre-Eclampsia | 2 | 2019 | 1229 | 0.400 |
Why?
|
Hemostasis, Surgical | 2 | 2010 | 129 | 0.390 |
Why?
|
Ruthenium Red | 3 | 2007 | 19 | 0.390 |
Why?
|
Erythema | 1 | 2013 | 262 | 0.390 |
Why?
|
Intracranial Aneurysm | 1 | 2021 | 1276 | 0.380 |
Why?
|
Living Donors | 3 | 2014 | 636 | 0.380 |
Why?
|
Metabolic Diseases | 1 | 2018 | 686 | 0.380 |
Why?
|
Rats, Zucker | 5 | 2015 | 132 | 0.380 |
Why?
|
Temperature | 1 | 2018 | 2221 | 0.380 |
Why?
|
Cholesterol | 2 | 2020 | 2924 | 0.370 |
Why?
|
Immunocompromised Host | 1 | 2016 | 857 | 0.370 |
Why?
|
Ischemia | 5 | 2019 | 1893 | 0.360 |
Why?
|
Genes, Mitochondrial | 1 | 2010 | 62 | 0.360 |
Why?
|
Intracranial Embolism | 2 | 2018 | 192 | 0.360 |
Why?
|
Calcium | 6 | 2019 | 5725 | 0.360 |
Why?
|
Genetic Association Studies | 7 | 2018 | 2717 | 0.360 |
Why?
|
Apolipoproteins E | 6 | 2019 | 1436 | 0.350 |
Why?
|
Models, Animal | 4 | 2019 | 2117 | 0.340 |
Why?
|
Critical Care | 2 | 2020 | 2699 | 0.340 |
Why?
|
Pneumonia | 3 | 2018 | 2131 | 0.340 |
Why?
|
Thrombin | 2 | 2010 | 593 | 0.340 |
Why?
|
Graft Survival | 9 | 2014 | 3794 | 0.340 |
Why?
|
Anticoagulants | 8 | 2023 | 4897 | 0.340 |
Why?
|
Apoptosis | 4 | 2013 | 9501 | 0.330 |
Why?
|
Cell Death | 2 | 2004 | 1672 | 0.320 |
Why?
|
Biliary Tract Diseases | 1 | 2009 | 157 | 0.320 |
Why?
|
Genes | 1 | 2013 | 1845 | 0.320 |
Why?
|
Methanol | 2 | 2008 | 91 | 0.320 |
Why?
|
Dioxolanes | 1 | 2008 | 25 | 0.310 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2021 | 578 | 0.310 |
Why?
|
Genomics | 3 | 2023 | 5794 | 0.310 |
Why?
|
Cholestasis | 1 | 2011 | 377 | 0.310 |
Why?
|
Neurologic Examination | 1 | 2011 | 916 | 0.310 |
Why?
|
RNA, Viral | 2 | 2016 | 2838 | 0.310 |
Why?
|
Cholangiocarcinoma | 2 | 2004 | 550 | 0.310 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2010 | 534 | 0.310 |
Why?
|
Risk Assessment | 17 | 2024 | 24123 | 0.300 |
Why?
|
Glutamic Acid | 1 | 2013 | 1167 | 0.300 |
Why?
|
Cohort Studies | 28 | 2024 | 41335 | 0.300 |
Why?
|
Liver Failure | 3 | 2013 | 249 | 0.300 |
Why?
|
Epilepsy | 1 | 2023 | 3267 | 0.300 |
Why?
|
Membrane Proteins | 2 | 2015 | 7850 | 0.290 |
Why?
|
Eczema | 2 | 2023 | 245 | 0.290 |
Why?
|
Cerebral Angiography | 4 | 2018 | 1274 | 0.290 |
Why?
|
Naphthalenes | 1 | 2008 | 198 | 0.290 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2007 | 72 | 0.280 |
Why?
|
Kidney Diseases | 1 | 2018 | 2093 | 0.280 |
Why?
|
Leukoaraiosis | 2 | 2020 | 116 | 0.280 |
Why?
|
Genotype | 16 | 2019 | 12960 | 0.280 |
Why?
|
Sepsis | 2 | 2018 | 2592 | 0.280 |
Why?
|
Tissue Preservation | 1 | 2007 | 174 | 0.280 |
Why?
|
Hepatitis C | 3 | 2011 | 1579 | 0.270 |
Why?
|
Sex Characteristics | 1 | 2017 | 2629 | 0.270 |
Why?
|
Tissue Plasminogen Activator | 2 | 2020 | 1190 | 0.270 |
Why?
|
Magnesium | 2 | 2021 | 810 | 0.270 |
Why?
|
Kidney | 2 | 2020 | 7064 | 0.270 |
Why?
|
Warfarin | 4 | 2017 | 1518 | 0.270 |
Why?
|
Case-Control Studies | 20 | 2023 | 22053 | 0.270 |
Why?
|
Decompression, Surgical | 1 | 2011 | 604 | 0.270 |
Why?
|
Liver Diseases | 2 | 2012 | 1302 | 0.270 |
Why?
|
Catheterization | 1 | 2011 | 1432 | 0.260 |
Why?
|
Blood Pressure | 10 | 2024 | 8525 | 0.260 |
Why?
|
Cyclic N-Oxides | 1 | 2005 | 73 | 0.260 |
Why?
|
Aspartate Aminotransferase, Mitochondrial | 1 | 2005 | 2 | 0.260 |
Why?
|
Drainage | 1 | 2011 | 1161 | 0.260 |
Why?
|
Immunity | 1 | 2011 | 998 | 0.260 |
Why?
|
Disease Management | 1 | 2016 | 2514 | 0.250 |
Why?
|
Genetic Loci | 6 | 2021 | 2618 | 0.250 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2014 | 2299 | 0.250 |
Why?
|
Hepacivirus | 2 | 2011 | 1334 | 0.250 |
Why?
|
Prefrontal Cortex | 3 | 2021 | 2212 | 0.250 |
Why?
|
Ticlopidine | 1 | 2010 | 895 | 0.240 |
Why?
|
Glomerular Filtration Rate | 3 | 2024 | 2180 | 0.240 |
Why?
|
Swine | 3 | 2020 | 5899 | 0.240 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1132 | 0.240 |
Why?
|
Cholesterol, LDL | 4 | 2022 | 2420 | 0.230 |
Why?
|
Dermoscopy | 1 | 2024 | 66 | 0.230 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 2782 | 0.230 |
Why?
|
Psoriasis | 1 | 2012 | 940 | 0.220 |
Why?
|
Cholesterol, HDL | 3 | 2020 | 1817 | 0.220 |
Why?
|
Linkage Disequilibrium | 3 | 2020 | 1996 | 0.220 |
Why?
|
Rats | 11 | 2019 | 23711 | 0.220 |
Why?
|
Stress, Physiological | 1 | 2011 | 1398 | 0.220 |
Why?
|
Administration, Cutaneous | 2 | 2018 | 713 | 0.220 |
Why?
|
Postoperative Complications | 4 | 2016 | 15697 | 0.210 |
Why?
|
Incidence | 11 | 2022 | 21392 | 0.210 |
Why?
|
Dioxanes | 1 | 2002 | 36 | 0.210 |
Why?
|
Statistics as Topic | 2 | 2019 | 2362 | 0.210 |
Why?
|
Catheter Ablation | 3 | 2004 | 2758 | 0.210 |
Why?
|
Chemokine CXCL10 | 1 | 2023 | 316 | 0.210 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1902 | 0.210 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2004 | 296 | 0.200 |
Why?
|
C-Reactive Protein | 3 | 2023 | 3839 | 0.200 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2003 | 100 | 0.200 |
Why?
|
Stereoisomerism | 7 | 2009 | 617 | 0.200 |
Why?
|
Severity of Illness Index | 10 | 2024 | 15840 | 0.200 |
Why?
|
Hernia, Hiatal | 1 | 2003 | 90 | 0.200 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18137 | 0.200 |
Why?
|
Gallbladder Neoplasms | 1 | 2004 | 190 | 0.200 |
Why?
|
Taurochenodeoxycholic Acid | 2 | 2013 | 35 | 0.200 |
Why?
|
Lung Transplantation | 1 | 2011 | 1305 | 0.200 |
Why?
|
Longitudinal Studies | 12 | 2022 | 14495 | 0.200 |
Why?
|
Biliary Tract Neoplasms | 1 | 2004 | 184 | 0.200 |
Why?
|
Adenosine Triphosphate | 2 | 2007 | 1993 | 0.190 |
Why?
|
Research | 2 | 2022 | 1974 | 0.190 |
Why?
|
Adult | 37 | 2024 | 219994 | 0.190 |
Why?
|
Portal Vein | 1 | 2004 | 429 | 0.190 |
Why?
|
Diaphragm | 1 | 2003 | 351 | 0.190 |
Why?
|
Recurrence | 8 | 2021 | 8482 | 0.190 |
Why?
|
Neural Pathways | 3 | 2021 | 3040 | 0.190 |
Why?
|
Survivors | 3 | 2023 | 2375 | 0.190 |
Why?
|
Nervous System Diseases | 1 | 2011 | 1647 | 0.190 |
Why?
|
Mannose-Binding Lectin | 1 | 2022 | 146 | 0.180 |
Why?
|
Seizures | 3 | 2023 | 2917 | 0.180 |
Why?
|
Prospective Studies | 20 | 2024 | 54303 | 0.180 |
Why?
|
Interleukin-6 | 3 | 2023 | 3215 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 21 | 2024 | 36290 | 0.180 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 1121 | 0.180 |
Why?
|
Dielectric Spectroscopy | 1 | 2020 | 30 | 0.180 |
Why?
|
Valproic Acid | 1 | 2023 | 441 | 0.180 |
Why?
|
Animals | 25 | 2024 | 167963 | 0.180 |
Why?
|
Intracranial Hemorrhages | 2 | 2016 | 844 | 0.180 |
Why?
|
Models, Molecular | 3 | 2009 | 5434 | 0.180 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 20 | 0.170 |
Why?
|
Kidney Function Tests | 2 | 2020 | 681 | 0.170 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6538 | 0.170 |
Why?
|
Infusions, Intravenous | 1 | 2005 | 2234 | 0.170 |
Why?
|
Vasodilation | 2 | 2024 | 962 | 0.170 |
Why?
|
Arteriolosclerosis | 1 | 2019 | 21 | 0.170 |
Why?
|
Alleles | 3 | 2018 | 6898 | 0.170 |
Why?
|
Skin Physiological Phenomena | 1 | 2020 | 188 | 0.170 |
Why?
|
Time Factors | 14 | 2024 | 40165 | 0.170 |
Why?
|
Microcirculation | 1 | 2024 | 1278 | 0.170 |
Why?
|
Retrospective Studies | 24 | 2024 | 80372 | 0.170 |
Why?
|
Brain | 8 | 2024 | 26951 | 0.170 |
Why?
|
Keratosis, Actinic | 1 | 2020 | 72 | 0.170 |
Why?
|
Hyperlipidemias | 3 | 2019 | 782 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2022 | 3334 | 0.160 |
Why?
|
Cryopreservation | 1 | 2004 | 717 | 0.160 |
Why?
|
Proteins | 1 | 2013 | 6029 | 0.160 |
Why?
|
Sweden | 4 | 2024 | 1381 | 0.160 |
Why?
|
Length of Stay | 2 | 2011 | 6479 | 0.160 |
Why?
|
Transplantation, Homologous | 3 | 2011 | 4810 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 14 | 2022 | 20509 | 0.160 |
Why?
|
Polymers | 1 | 2005 | 1621 | 0.150 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2019 | 128 | 0.150 |
Why?
|
PPAR alpha | 1 | 2019 | 174 | 0.150 |
Why?
|
Bile Duct Neoplasms | 1 | 2004 | 602 | 0.150 |
Why?
|
Intensive Care Units | 1 | 2011 | 3736 | 0.150 |
Why?
|
Obesity | 5 | 2023 | 12922 | 0.150 |
Why?
|
Atrophy | 2 | 2020 | 1627 | 0.150 |
Why?
|
Placental Insufficiency | 1 | 2018 | 50 | 0.150 |
Why?
|
Forehead | 1 | 2018 | 74 | 0.150 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2010 | 3201 | 0.150 |
Why?
|
Excipients | 1 | 2017 | 97 | 0.150 |
Why?
|
Remote Consultation | 1 | 2020 | 234 | 0.140 |
Why?
|
Thromboembolism | 1 | 2024 | 1017 | 0.140 |
Why?
|
Pharmacogenetics | 1 | 2021 | 680 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1407 | 0.140 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1689 | 0.140 |
Why?
|
Chaplaincy Service, Hospital | 1 | 2017 | 22 | 0.140 |
Why?
|
Mitochondria | 3 | 2007 | 3600 | 0.140 |
Why?
|
Gene Frequency | 4 | 2014 | 3615 | 0.140 |
Why?
|
Silicon | 1 | 2017 | 142 | 0.140 |
Why?
|
Sternum | 1 | 2018 | 175 | 0.140 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 2221 | 0.140 |
Why?
|
Catalysis | 3 | 2008 | 775 | 0.140 |
Why?
|
Hand Dermatoses | 1 | 2017 | 62 | 0.140 |
Why?
|
Hospital Mortality | 2 | 2024 | 5425 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2013 | 8950 | 0.140 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2018 | 419 | 0.140 |
Why?
|
Follow-Up Studies | 15 | 2024 | 39261 | 0.140 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15289 | 0.140 |
Why?
|
Placenta Diseases | 1 | 2019 | 196 | 0.140 |
Why?
|
Biliary Atresia | 2 | 2014 | 88 | 0.140 |
Why?
|
Age Factors | 9 | 2024 | 18416 | 0.130 |
Why?
|
Caspase 3 | 2 | 2012 | 731 | 0.130 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2016 | 46 | 0.130 |
Why?
|
Chemokine CCL2 | 1 | 2019 | 605 | 0.130 |
Why?
|
Hypoalbuminemia | 1 | 2017 | 87 | 0.130 |
Why?
|
Alcohols | 2 | 2007 | 94 | 0.130 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15757 | 0.130 |
Why?
|
Stomach Diseases | 1 | 2017 | 133 | 0.130 |
Why?
|
Sex Factors | 6 | 2024 | 10547 | 0.130 |
Why?
|
Pastoral Care | 1 | 2017 | 72 | 0.130 |
Why?
|
Models, Cardiovascular | 1 | 2021 | 978 | 0.130 |
Why?
|
Observer Variation | 2 | 2019 | 2601 | 0.130 |
Why?
|
Treatment Outcome | 18 | 2021 | 65017 | 0.130 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 854 | 0.130 |
Why?
|
Choristoma | 1 | 2017 | 207 | 0.130 |
Why?
|
Spectrum Analysis, Raman | 1 | 2017 | 237 | 0.130 |
Why?
|
Multifactorial Inheritance | 2 | 2022 | 1365 | 0.130 |
Why?
|
Tissue and Organ Procurement | 2 | 2014 | 944 | 0.130 |
Why?
|
Dermatitis, Atopic | 1 | 2023 | 716 | 0.130 |
Why?
|
Carotid Artery Diseases | 1 | 2022 | 883 | 0.130 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2017 | 342 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2017 | 386 | 0.130 |
Why?
|
Pons | 1 | 2016 | 239 | 0.120 |
Why?
|
Models, Genetic | 3 | 2021 | 3442 | 0.120 |
Why?
|
Hypocalcemia | 1 | 2016 | 199 | 0.120 |
Why?
|
Cytochromes c | 2 | 2007 | 173 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2004 | 2007 | 0.120 |
Why?
|
Missouri | 2 | 2011 | 114 | 0.120 |
Why?
|
Europe | 5 | 2022 | 3441 | 0.120 |
Why?
|
Brain Stem Hemorrhage, Traumatic | 1 | 2014 | 13 | 0.120 |
Why?
|
Fingers | 1 | 2018 | 506 | 0.120 |
Why?
|
Lymphopenia | 1 | 2017 | 280 | 0.120 |
Why?
|
Zinc Fingers | 1 | 2017 | 568 | 0.120 |
Why?
|
Caspases | 2 | 2011 | 878 | 0.120 |
Why?
|
Rats, Wistar | 1 | 2018 | 1850 | 0.120 |
Why?
|
Carcinoma, Basal Cell | 1 | 2020 | 559 | 0.120 |
Why?
|
Cadaver | 2 | 2019 | 1345 | 0.120 |
Why?
|
bcl-2-Associated X Protein | 2 | 2007 | 282 | 0.120 |
Why?
|
Drug Discovery | 1 | 2022 | 1057 | 0.120 |
Why?
|
Embolization, Therapeutic | 1 | 2004 | 1413 | 0.120 |
Why?
|
Type C Phospholipases | 2 | 2006 | 287 | 0.120 |
Why?
|
Mitochondria, Liver | 2 | 2006 | 190 | 0.120 |
Why?
|
Peroxidase | 1 | 2017 | 605 | 0.120 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1490 | 0.120 |
Why?
|
Depression | 3 | 2022 | 8044 | 0.110 |
Why?
|
Radiopharmaceuticals | 1 | 2004 | 2634 | 0.110 |
Why?
|
Plasma | 1 | 2017 | 584 | 0.110 |
Why?
|
Head | 1 | 2019 | 922 | 0.110 |
Why?
|
Serum Albumin | 1 | 2017 | 674 | 0.110 |
Why?
|
Principal Component Analysis | 3 | 2014 | 940 | 0.110 |
Why?
|
Embolism | 1 | 2017 | 408 | 0.110 |
Why?
|
Melanoma | 2 | 2024 | 5697 | 0.110 |
Why?
|
Hepatorenal Syndrome | 1 | 2014 | 76 | 0.110 |
Why?
|
Electronic Health Records | 4 | 2024 | 4775 | 0.110 |
Why?
|
Natural Language Processing | 1 | 2022 | 1135 | 0.110 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2017 | 517 | 0.110 |
Why?
|
Antineoplastic Agents | 3 | 2013 | 13630 | 0.110 |
Why?
|
Tunicamycin | 1 | 2013 | 108 | 0.110 |
Why?
|
Cerebral Infarction | 2 | 2015 | 982 | 0.110 |
Why?
|
Molecular Structure | 5 | 2008 | 1895 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2020 | 2698 | 0.110 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 2013 | 59 | 0.110 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2019 | 518 | 0.110 |
Why?
|
Lung | 1 | 2011 | 9994 | 0.110 |
Why?
|
Heart Rate | 1 | 2024 | 4179 | 0.100 |
Why?
|
Survival Rate | 6 | 2021 | 12808 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5799 | 0.100 |
Why?
|
Electron Transport Complex I | 1 | 2014 | 152 | 0.100 |
Why?
|
Cytosol | 2 | 2007 | 887 | 0.100 |
Why?
|
Nanostructures | 1 | 2017 | 547 | 0.100 |
Why?
|
Placenta | 2 | 2019 | 1702 | 0.100 |
Why?
|
Liver Failure, Acute | 1 | 2014 | 181 | 0.100 |
Why?
|
Cerebellar Diseases | 1 | 2014 | 219 | 0.100 |
Why?
|
Overweight | 1 | 2023 | 2421 | 0.100 |
Why?
|
Risk | 4 | 2018 | 9631 | 0.100 |
Why?
|
Choledochal Cyst | 1 | 2012 | 25 | 0.100 |
Why?
|
Odds Ratio | 5 | 2021 | 9716 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2016 | 1600 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 936 | 0.100 |
Why?
|
Endothelium, Vascular | 2 | 2024 | 4433 | 0.100 |
Why?
|
Chromatin | 1 | 2023 | 2938 | 0.100 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2014 | 635 | 0.100 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2013 | 461 | 0.100 |
Why?
|
Transaminases | 1 | 2012 | 196 | 0.100 |
Why?
|
Cholangiography | 1 | 2011 | 181 | 0.100 |
Why?
|
Androstadienes | 1 | 2013 | 348 | 0.090 |
Why?
|
Alzheimer Disease | 5 | 2014 | 8547 | 0.090 |
Why?
|
Tissue Culture Techniques | 1 | 2012 | 290 | 0.090 |
Why?
|
Coronary Artery Disease | 3 | 2024 | 6659 | 0.090 |
Why?
|
Prognosis | 8 | 2024 | 29658 | 0.090 |
Why?
|
Hepatitis B Antibodies | 1 | 2011 | 157 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 11903 | 0.090 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2012 | 313 | 0.090 |
Why?
|
Acrolein | 2 | 2009 | 18 | 0.090 |
Why?
|
Statistics, Nonparametric | 4 | 2017 | 2852 | 0.090 |
Why?
|
Child | 9 | 2023 | 79806 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1895 | 0.090 |
Why?
|
Amyloid beta-Peptides | 2 | 2023 | 3832 | 0.090 |
Why?
|
Hemodynamics | 2 | 2019 | 4174 | 0.090 |
Why?
|
Liver Cirrhosis | 2 | 2011 | 1931 | 0.090 |
Why?
|
Radiography | 4 | 2015 | 6965 | 0.090 |
Why?
|
Young Adult | 11 | 2024 | 58741 | 0.090 |
Why?
|
Influenza Vaccines | 1 | 2018 | 766 | 0.090 |
Why?
|
Jejunal Neoplasms | 1 | 2010 | 19 | 0.090 |
Why?
|
Activating Transcription Factor 4 | 1 | 2011 | 82 | 0.090 |
Why?
|
Pancreas | 1 | 2017 | 1677 | 0.090 |
Why?
|
Forearm | 1 | 2013 | 429 | 0.090 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2013 | 632 | 0.090 |
Why?
|
Registries | 4 | 2023 | 8469 | 0.090 |
Why?
|
Lipoproteins | 1 | 2015 | 882 | 0.090 |
Why?
|
Medulla Oblongata | 1 | 2011 | 248 | 0.090 |
Why?
|
Health Care Rationing | 1 | 2013 | 435 | 0.090 |
Why?
|
Kinetics | 1 | 2018 | 6377 | 0.090 |
Why?
|
Colorectal Neoplasms | 1 | 2010 | 6853 | 0.090 |
Why?
|
Specimen Handling | 1 | 2014 | 707 | 0.090 |
Why?
|
Pyramidal Tracts | 1 | 2011 | 250 | 0.090 |
Why?
|
Protein Transport | 2 | 2007 | 1964 | 0.090 |
Why?
|
Glasgow Coma Scale | 1 | 2011 | 579 | 0.080 |
Why?
|
Pregnancy | 4 | 2019 | 29749 | 0.080 |
Why?
|
Boronic Acids | 1 | 2013 | 914 | 0.080 |
Why?
|
Waiting Lists | 1 | 2014 | 763 | 0.080 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 829 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2754 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1864 | 0.080 |
Why?
|
Survival Analysis | 5 | 2021 | 10182 | 0.080 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 253 | 0.080 |
Why?
|
Biopsy | 2 | 2011 | 6771 | 0.080 |
Why?
|
Blood Specimen Collection | 1 | 2010 | 238 | 0.080 |
Why?
|
Hepatoblastoma | 2 | 2013 | 88 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12159 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2021 | 3811 | 0.080 |
Why?
|
Protein Array Analysis | 1 | 2010 | 401 | 0.080 |
Why?
|
Lipids | 1 | 2020 | 3336 | 0.080 |
Why?
|
Reoperation | 4 | 2011 | 4291 | 0.080 |
Why?
|
Alkenes | 1 | 2008 | 54 | 0.080 |
Why?
|
Cells, Cultured | 2 | 2015 | 18957 | 0.080 |
Why?
|
Hepatitis B virus | 1 | 2011 | 522 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2024 | 14372 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2019 | 20080 | 0.080 |
Why?
|
Pyrazines | 1 | 2013 | 1199 | 0.070 |
Why?
|
Molecular Chaperones | 1 | 2012 | 752 | 0.070 |
Why?
|
Primary Health Care | 1 | 2024 | 4647 | 0.070 |
Why?
|
Tracheostomy | 1 | 2011 | 425 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2023 | 3517 | 0.070 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2008 | 127 | 0.070 |
Why?
|
Hemostatics | 1 | 2010 | 243 | 0.070 |
Why?
|
Chemokines | 1 | 2011 | 962 | 0.070 |
Why?
|
Preoperative Care | 2 | 2008 | 2256 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2024 | 14660 | 0.070 |
Why?
|
Inflammation Mediators | 2 | 2019 | 1881 | 0.070 |
Why?
|
Boron Compounds | 1 | 2009 | 180 | 0.070 |
Why?
|
Adenine | 1 | 2013 | 975 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2012 | 1387 | 0.070 |
Why?
|
Hydrocarbons, Acyclic | 1 | 2006 | 1 | 0.070 |
Why?
|
Hepatitis B, Chronic | 1 | 2011 | 403 | 0.070 |
Why?
|
Aldehydes | 1 | 2008 | 170 | 0.070 |
Why?
|
Benzaldehydes | 1 | 2007 | 59 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10790 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 795 | 0.070 |
Why?
|
Intestinal Obstruction | 1 | 2010 | 434 | 0.070 |
Why?
|
Influenza, Human | 1 | 2018 | 1528 | 0.070 |
Why?
|
Administration, Topical | 1 | 2009 | 697 | 0.070 |
Why?
|
Immunoassay | 1 | 2010 | 746 | 0.070 |
Why?
|
Models, Chemical | 2 | 2007 | 614 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7588 | 0.070 |
Why?
|
Neocortex | 1 | 2010 | 416 | 0.070 |
Why?
|
Dermatology | 1 | 2017 | 914 | 0.070 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 875 | 0.070 |
Why?
|
Genetic Testing | 1 | 2019 | 3531 | 0.070 |
Why?
|
Cognition Disorders | 3 | 2024 | 3976 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1724 | 0.070 |
Why?
|
Interleukin-10 | 1 | 2011 | 1175 | 0.070 |
Why?
|
Endosonography | 1 | 2010 | 607 | 0.070 |
Why?
|
Constriction, Pathologic | 1 | 2009 | 1098 | 0.070 |
Why?
|
Glycoproteins | 1 | 2013 | 2208 | 0.070 |
Why?
|
Hepatitis C, Chronic | 1 | 2014 | 1031 | 0.070 |
Why?
|
Arousal | 1 | 2011 | 1157 | 0.060 |
Why?
|
Lactones | 1 | 2008 | 319 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3442 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2011 | 910 | 0.060 |
Why?
|
Body Mass Index | 5 | 2023 | 12914 | 0.060 |
Why?
|
Treatment Failure | 1 | 2011 | 2648 | 0.060 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12531 | 0.060 |
Why?
|
Triazines | 1 | 2007 | 310 | 0.060 |
Why?
|
Genetics, Population | 1 | 2010 | 930 | 0.060 |
Why?
|
Liver Circulation | 1 | 2005 | 159 | 0.060 |
Why?
|
Proteomics | 2 | 2023 | 3817 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2011 | 998 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2011 | 11152 | 0.060 |
Why?
|
DNA, Mitochondrial | 1 | 2010 | 858 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2012 | 1415 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 616 | 0.060 |
Why?
|
Adenine Nucleotides | 1 | 2004 | 111 | 0.060 |
Why?
|
Blood Coagulation | 1 | 2010 | 1157 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4024 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2709 | 0.060 |
Why?
|
Reperfusion | 1 | 2005 | 271 | 0.060 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2010 | 615 | 0.060 |
Why?
|
Quantitative Trait Loci | 3 | 2018 | 2101 | 0.060 |
Why?
|
Optical Fibers | 1 | 2004 | 135 | 0.060 |
Why?
|
Biosensing Techniques | 1 | 2010 | 677 | 0.060 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2010 | 806 | 0.060 |
Why?
|
Child, Preschool | 6 | 2013 | 42063 | 0.060 |
Why?
|
Disease Progression | 5 | 2020 | 13502 | 0.060 |
Why?
|
Acetates | 1 | 2005 | 321 | 0.060 |
Why?
|
Secondary Prevention | 2 | 2024 | 1548 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2011 | 1726 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1287 | 0.060 |
Why?
|
Cold Temperature | 1 | 2007 | 780 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 2 | 2013 | 1431 | 0.050 |
Why?
|
Inflammation | 2 | 2021 | 10756 | 0.050 |
Why?
|
Receptors, Purinergic P2 | 1 | 2004 | 151 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2011 | 3157 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2004 | 461 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2012 | 5201 | 0.050 |
Why?
|
Optical Rotation | 1 | 2002 | 12 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2018 | 1578 | 0.050 |
Why?
|
Cell Survival | 1 | 2013 | 5797 | 0.050 |
Why?
|
Collagen | 1 | 2011 | 2636 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2010 | 1266 | 0.050 |
Why?
|
Fiber Optic Technology | 1 | 2004 | 289 | 0.050 |
Why?
|
Dogs | 2 | 2004 | 3841 | 0.050 |
Why?
|
Adolescent | 10 | 2024 | 87810 | 0.050 |
Why?
|
Hypertrophy | 1 | 2024 | 555 | 0.050 |
Why?
|
Alanine Transaminase | 1 | 2005 | 606 | 0.050 |
Why?
|
Polytetrafluoroethylene | 1 | 2003 | 245 | 0.050 |
Why?
|
NF-kappa B | 1 | 2011 | 2488 | 0.050 |
Why?
|
Methods | 1 | 2002 | 1074 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 2 | 2024 | 2385 | 0.050 |
Why?
|
United States | 7 | 2021 | 72461 | 0.050 |
Why?
|
Germany | 1 | 2024 | 873 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3446 | 0.050 |
Why?
|
Carcinoid Tumor | 1 | 2003 | 228 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2006 | 8158 | 0.050 |
Why?
|
Dementia | 1 | 2016 | 2649 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2005 | 732 | 0.050 |
Why?
|
Phenotype | 4 | 2024 | 16546 | 0.050 |
Why?
|
Drug Repositioning | 1 | 2024 | 232 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2010 | 2821 | 0.050 |
Why?
|
Biological Factors | 1 | 2002 | 157 | 0.050 |
Why?
|
Databases, Factual | 3 | 2024 | 8035 | 0.050 |
Why?
|
Hong Kong | 1 | 2021 | 162 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2471 | 0.050 |
Why?
|
Lipogenesis | 1 | 2022 | 210 | 0.050 |
Why?
|
Logistic Models | 4 | 2018 | 13314 | 0.050 |
Why?
|
Necrosis | 1 | 2005 | 1612 | 0.050 |
Why?
|
Albuminuria | 1 | 2024 | 659 | 0.050 |
Why?
|
Antihypertensive Agents | 2 | 2024 | 2061 | 0.040 |
Why?
|
Diphosphonates | 1 | 2005 | 638 | 0.040 |
Why?
|
Peripheral Arterial Disease | 2 | 2023 | 1306 | 0.040 |
Why?
|
Surgical Mesh | 1 | 2003 | 311 | 0.040 |
Why?
|
Africa | 1 | 2022 | 705 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2802 | 0.040 |
Why?
|
Antidepressive Agents | 2 | 2022 | 2890 | 0.040 |
Why?
|
Japan | 1 | 2024 | 1369 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2475 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2012 | 3047 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2017 | 5351 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 8056 | 0.040 |
Why?
|
Isoenzymes | 1 | 2004 | 1690 | 0.040 |
Why?
|
Stents | 1 | 2011 | 3314 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 322 | 0.040 |
Why?
|
Signal Transduction | 2 | 2014 | 23376 | 0.040 |
Why?
|
Adenosine | 1 | 2004 | 834 | 0.040 |
Why?
|
Apolipoprotein B-100 | 1 | 2019 | 155 | 0.040 |
Why?
|
Mutation | 2 | 2023 | 29932 | 0.040 |
Why?
|
Biological Products | 1 | 2008 | 916 | 0.040 |
Why?
|
Cerebral Cortex | 2 | 2013 | 5761 | 0.040 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 2018 | 86 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2020 | 516 | 0.040 |
Why?
|
Recovery of Function | 2 | 2019 | 2985 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4215 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 1791 | 0.040 |
Why?
|
Automation | 1 | 2020 | 580 | 0.040 |
Why?
|
Hot Temperature | 1 | 2004 | 1435 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4048 | 0.040 |
Why?
|
Education | 1 | 2021 | 534 | 0.040 |
Why?
|
Vaccines, Inactivated | 1 | 2018 | 180 | 0.040 |
Why?
|
Antioxidants | 1 | 2005 | 1667 | 0.040 |
Why?
|
Algorithms | 2 | 2020 | 13981 | 0.040 |
Why?
|
Organ Size | 2 | 2014 | 2254 | 0.040 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 266 | 0.040 |
Why?
|
Cyclization | 2 | 2008 | 61 | 0.040 |
Why?
|
Australia | 1 | 2021 | 1289 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2004 | 1489 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 266 | 0.040 |
Why?
|
New England | 1 | 2020 | 1050 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2002 | 3084 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11071 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7475 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2019 | 6238 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2019 | 494 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2018 | 553 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 22023 | 0.030 |
Why?
|
Models, Biological | 1 | 2013 | 9467 | 0.030 |
Why?
|
Molecular Conformation | 2 | 2009 | 548 | 0.030 |
Why?
|
Surgery, Computer-Assisted | 1 | 2004 | 1008 | 0.030 |
Why?
|
Hydrogen Bonding | 2 | 2007 | 291 | 0.030 |
Why?
|
Blood Component Transfusion | 1 | 2017 | 141 | 0.030 |
Why?
|
Lymphoproliferative Disorders | 2 | 2010 | 533 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2004 | 6131 | 0.030 |
Why?
|
Needles | 1 | 2019 | 451 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2773 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25942 | 0.030 |
Why?
|
Massachusetts | 2 | 2020 | 8803 | 0.030 |
Why?
|
Research Subjects | 1 | 2017 | 249 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5791 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10551 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2004 | 3529 | 0.030 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2019 | 516 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2024 | 2566 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2017 | 225 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 852 | 0.030 |
Why?
|
Decision Support Systems, Clinical | 1 | 2024 | 1164 | 0.030 |
Why?
|
Leukocytosis | 1 | 2016 | 251 | 0.030 |
Why?
|
Infant | 3 | 2011 | 36060 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 819 | 0.030 |
Why?
|
Vitamin K | 1 | 2017 | 321 | 0.030 |
Why?
|
Fatty Acids | 1 | 2022 | 1804 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 665 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15687 | 0.030 |
Why?
|
Computational Biology | 2 | 2018 | 3505 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1403 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 934 | 0.030 |
Why?
|
Antifibrinolytic Agents | 1 | 2017 | 292 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1668 | 0.030 |
Why?
|
Smoking | 2 | 2021 | 9073 | 0.030 |
Why?
|
Mice | 3 | 2024 | 81208 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2021 | 1688 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2023 | 2050 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1570 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3568 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1500 | 0.030 |
Why?
|
Hospitals, University | 1 | 2014 | 568 | 0.030 |
Why?
|
Aging | 1 | 2011 | 8651 | 0.030 |
Why?
|
Warm Ischemia | 1 | 2012 | 58 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 283 | 0.030 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 6 | 0.030 |
Why?
|
Entorhinal Cortex | 1 | 2014 | 286 | 0.030 |
Why?
|
Biomedical Research | 2 | 2021 | 3426 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 13308 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1047 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3539 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1913 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2015 | 640 | 0.020 |
Why?
|
Program Evaluation | 1 | 2020 | 2493 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2326 | 0.020 |
Why?
|
Quality Control | 1 | 2014 | 828 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1738 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2022 | 2803 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3465 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2108 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2016 | 7021 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 16939 | 0.020 |
Why?
|
Basal Ganglia | 1 | 2013 | 552 | 0.020 |
Why?
|
Databases, Protein | 1 | 2012 | 388 | 0.020 |
Why?
|
Hernia, Diaphragmatic | 1 | 2010 | 246 | 0.020 |
Why?
|
Hippocampus | 2 | 2014 | 3738 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4035 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6828 | 0.020 |
Why?
|
Adiposity | 1 | 2019 | 1858 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2004 | 3527 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9287 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5877 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1741 | 0.020 |
Why?
|
Nerve Net | 1 | 2021 | 2261 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2017 | 4625 | 0.020 |
Why?
|
Population Groups | 1 | 2010 | 211 | 0.020 |
Why?
|
Butadienes | 1 | 2009 | 107 | 0.020 |
Why?
|
Acrylates | 1 | 2009 | 79 | 0.020 |
Why?
|
Vaccines | 1 | 2017 | 832 | 0.020 |
Why?
|
Micromonospora | 1 | 2008 | 4 | 0.020 |
Why?
|
Graft Rejection | 2 | 2014 | 4426 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1544 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2008 | 182 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4611 | 0.020 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2010 | 263 | 0.020 |
Why?
|
Palliative Care | 1 | 2004 | 3607 | 0.020 |
Why?
|
Benzoquinones | 1 | 2009 | 198 | 0.020 |
Why?
|
Fumarates | 1 | 2009 | 131 | 0.020 |
Why?
|
Pain Measurement | 1 | 2018 | 3528 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 848 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3602 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 633 | 0.020 |
Why?
|
Thalamus | 1 | 2013 | 1041 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4081 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2018 | 3143 | 0.020 |
Why?
|
Perioperative Care | 1 | 2014 | 1037 | 0.020 |
Why?
|
Monocytes | 1 | 2016 | 2575 | 0.020 |
Why?
|
Blotting, Western | 2 | 2004 | 5039 | 0.020 |
Why?
|
Information Dissemination | 1 | 2014 | 1131 | 0.020 |
Why?
|
Transplants | 1 | 2008 | 206 | 0.020 |
Why?
|
Immune System | 1 | 2011 | 798 | 0.020 |
Why?
|
Bromides | 1 | 2005 | 22 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2010 | 1376 | 0.020 |
Why?
|
Syndrome | 1 | 2012 | 3280 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2011 | 979 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6381 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2012 | 2192 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 2913 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2010 | 1110 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2010 | 901 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5423 | 0.020 |
Why?
|
Coronary Disease | 1 | 2019 | 5990 | 0.020 |
Why?
|
Receptors, Purinergic P2Y2 | 1 | 2004 | 17 | 0.020 |
Why?
|
Phospholipase C delta | 1 | 2004 | 7 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2009 | 1792 | 0.010 |
Why?
|
Canada | 1 | 2010 | 2128 | 0.010 |
Why?
|
Estrenes | 1 | 2004 | 21 | 0.010 |
Why?
|
Calcium Channel Agonists | 1 | 2004 | 27 | 0.010 |
Why?
|
Receptors, Purinergic P2Y1 | 1 | 2004 | 42 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3758 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10344 | 0.010 |
Why?
|
Spermine | 1 | 2004 | 69 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 2004 | 306 | 0.010 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2004 | 110 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3164 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2013 | 2299 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3804 | 0.010 |
Why?
|
Steroids | 1 | 2009 | 928 | 0.010 |
Why?
|
Pyrrolidinones | 1 | 2004 | 116 | 0.010 |
Why?
|
Clinical Competence | 1 | 2019 | 4783 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2010 | 1328 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4122 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3767 | 0.010 |
Why?
|
Developmental Disabilities | 1 | 2012 | 1504 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2004 | 214 | 0.010 |
Why?
|
Patient Compliance | 1 | 2013 | 2688 | 0.010 |
Why?
|
Proteome | 1 | 2012 | 1855 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3520 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2007 | 1982 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6068 | 0.010 |
Why?
|
Biological Transport | 1 | 2006 | 2086 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3905 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2004 | 2558 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4417 | 0.010 |
Why?
|
Hyperthermia, Induced | 1 | 2004 | 417 | 0.010 |
Why?
|
Calcium Channels | 1 | 2004 | 619 | 0.010 |
Why?
|
tau Proteins | 1 | 2010 | 2085 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6544 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2004 | 1067 | 0.010 |
Why?
|
Pediatrics | 1 | 2013 | 3586 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2010 | 3340 | 0.010 |
Why?
|
Software | 1 | 2011 | 4419 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 2651 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10827 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4166 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2004 | 1913 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2003 | 2943 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2005 | 3765 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6218 | 0.010 |
Why?
|
Heart Failure | 1 | 2019 | 11847 | 0.010 |
Why?
|
Cell Membrane | 1 | 2004 | 3682 | 0.010 |
Why?
|
Burns | 1 | 2004 | 1866 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2003 | 9276 | 0.000 |
Why?
|